Cytomedix, Inc. (OTCBB: CMXI), a leading developer of biologically active regenerative therapies for wound 
care, inflammation and angiogenesis, today announced that the Company will release financial results for the three and twelve months ended December 31, 2011, following the close of the market on Thursday, March 29, 2012.
Martin Rosendale, Chief Executive Officer, and Andrew Maslan, Chief Financial Officer, will host a conference call beginning at 10:00 a.m. Eastern Time on Friday, March 30, 2012, to discuss the fourth quarter and year end 2011 financial results and to answer questions. Shareholders and other interested parties may participate in the call by dialing 888-679-8034 (domestic) or 617-213-4847 (international) and entering passcode 23291244. The call will also be broadcast live on the Internet at www.streetevents.com, www.fulldisclosure.com and www.cytomedix.com.
A replay of the conference call will be available beginning two hours after its completion through April 6, 2012 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 78509324. The call will also be archived for 90 days at www.streetevents.com, www.fulldisclosure.com and www.cytomedix.com.
